Acute lymphoblastic leukemia in a patient with Greig cephalopolysyndactyly and interstitial deletion of chromosome 7 del(7)(p11.2 p14) involving the GLI3 and ZNFN1A1 genes

Greig cephalopolysyndactyly (GCPS; OMIM 175700) is an autosomal dominant condition caused by mutations of the gene GLI3, located on 7p13. To date, several cases of deletions and/or translocations involving this locus have been reported in patients with GCPS. GLI3 is a transcription factor from the GLI‐Kruppel gene family that has been implicated in three distinct entities: GCPS, Pallister–Hall syndrome, and postaxial polydactyly type A. The zinc finger protein, subfamily 1, member 1 gene (ZNFN1A1; OMIM 603023), on 7p12, codes for a lymphoid‐restricted zinc finger transcription factor, ZNFN1A1, also called IKAROS, that regulates lymphocyte differentiation and has been associated with the development of childhood leukemia. We present the case of a 9‐year‐old Latin‐American boy who was referred for stem cell transplantation because of recurrent acute lymphoblastic leukemia (ALL). On evaluation, he was found to have dysmorphic features consistent with GCPS, including a prominent forehead, down‐slanting palpebral fissures, 1‐2‐3 toe syndactyly, broad thumbs and first toes, and mild developmental delay. He had developed ALL at 5 years of age. Chromosome analysis of bone marrow and fibroblastic cells showed an interstitial deletion of chromosome arm 7p, del(7)(p11.2p14), in 74% and 44% of the cells, respectively. We performed FISH analysis with a BAC clone containing the ZNFN1A1 gene and demonstrated that it is contained in the deleted segment. To our knowledge, this is the first report of a patient with GCPS and leukemia. We hypothesize that constitutional deletion of the ZNFN1A1 gene in this patient may have resulted in an increased risk of lymphoid malignancy. © 2005 Wiley‐Liss, Inc.

[1]  A. Zander,et al.  Atypical chronic myelogenous leukemia in a patient with trisomy 8 mosaicism syndrome , 2005, Annals of Hematology.

[2]  D. Ledbetter,et al.  Greig syndrome associated with an interstitial deletion of 7p: confirmation of the localization of Greig syndrome to 7p13 , 1991, Human Genetics.

[3]  L. Biesecker,et al.  Clinical and molecular delineation of the Greig cephalopolysyndactyly contiguous gene deletion syndrome and its distinction from acrocallosal syndrome , 2003, American journal of medical genetics. Part A.

[4]  H. Peeters,et al.  Variable phenotype in Greig cephalopolysyndactyly syndrome: Clinical and radiological findings in 4 independent families and 3 sporadic cases with identified GLI3 mutations , 2003, American journal of medical genetics. Part A.

[5]  A. Rebollo,et al.  Ikaros, Aiolos and Helios: Transcription regulators and lymphoid malignancies , 2003, Immunology and cell biology.

[6]  M. Potter,et al.  Lymphoma‐ and leukemia‐associated chromosomal translocations in healthy individuals , 2003, Genes, chromosomes & cancer.

[7]  高梨 万美 Expression of the Ikaros gene family in childhood acute lymphoblastic leukaemia , 2003 .

[8]  F. Ishimaru Expression of Ikaros isoforms in patients with acute myeloid leukemia. , 2002, Blood.

[9]  T. Imamura,et al.  Expression of the Ikaros gene family in childhood acute lymphoblastic leukaemia , 2002, British journal of haematology.

[10]  E. Petek,et al.  Phenotype of five patients with Greig syndrome and microdeletion of 7p13. , 2001, American journal of medical genetics.

[11]  J. Zuna,et al.  Importance of using comparative genomic hybridization to improve detection of chromosomal changes in childhood acute lymphoblastic leukemia. , 2000, Cancer genetics and cytogenetics.

[12]  K. Takenaka,et al.  Ikaros expression in human hematopoietic lineages. , 2000, Experimental hematology.

[13]  M. Seto,et al.  The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma. , 2000, Blood.

[14]  H. Sather,et al.  Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  R Rizzo,et al.  Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndrome. , 1999, Human molecular genetics.

[16]  K. Georgopoulos,et al.  Control of lymphocyte development by the Ikaros gene family. , 1999, Current opinion in immunology.

[17]  N. Heerema,et al.  Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Kalff-Suske,et al.  Greig cephalopolysyndactyly syndrome: altered phenotype of a microdeletion syndrome due to the presence of a cytogenetic abnormality , 1997, Clinical genetics.

[19]  L. Biesecker Strike three for GLI3 , 1997, Nature Genetics.

[20]  L. Secker-Walker,et al.  Constitutional and acquired trisomy 8. , 1995, Leukemia research.

[21]  M. Genuardi,et al.  Constitutional trisomy 8 and myelodysplasia: report of a case and review of the literature. , 1995, Leukemia research.

[22]  A. Sharpe,et al.  The ikaros gene is required for the development of all lymphoid lineages , 1994, Cell.

[23]  F. Speleman,et al.  Six cases of 7p deletion: clinical, cytogenetic, and molecular studies. , 1994, American journal of medical genetics.

[24]  C. Mecucci,et al.  Characterization of deletions of chromosome 7 short arm occurring as primary karyotypic anomaly in acute myeloid leukaemia , 1989, British journal of haematology.

[25]  M. Ridler,et al.  Partial monosomy 7 with interstitial deletions in two infants with differing congenital abnormalities. , 1979, Journal of medical genetics.